Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $5.02 USD
Change Today -0.35 / -6.52%
Volume 31.5K
As of 8:10 PM 04/17/15 All times are local (Market data is delayed by at least 15 minutes).

caredx inc (CDNA) Snapshot

Previous Close
Day High
Day Low
52 Week High
09/8/14 - $10.89
52 Week Low
04/17/15 - $4.92
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for CAREDX INC (CDNA)

Related News

No related news articles were found.

caredx inc (CDNA) Related Businessweek News

No Related Businessweek News Found

caredx inc (CDNA) Details

CareDx, Inc, a commercial stage company, develops, markets, and delivers diagnostic surveillance solutions for heart transplant recipients to help clinicians make personalized treatment decisions throughout a transplant patient’s lifetime. Its commercialized testing solution includes the AlloMap heart transplant molecular test (AlloMap), a blood-based test used to monitor heart transplant recipients for acute cellular rejection. The company markets its AlloMap solution to healthcare providers through its direct sales force that targets transplant centers and their physicians, coordinators, and nurse practitioners in the United States, Canada, and Europe. The company was formerly known as XDx, Inc. and changed its name to CareDx, Inc. in March 2014. CareDx, Inc. was incorporated in 1998 and is headquartered in Brisbane, California.

68 Employees
Last Reported Date: 03/31/15
Founded in 1998

caredx inc (CDNA) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $350.0K
Chief Medical Officer and Executive Vice Pres...
Total Annual Compensation: $365.7K
Chief Compliance Officer and Chief Business O...
Total Annual Compensation: $308.3K
Compensation as of Fiscal Year 2013.

caredx inc (CDNA) Key Developments

CareDx, Inc - Shareholder/Analyst Call

CareDx, Inc - Shareholder/Analyst Call

CareDx, Inc Announces Financial Results for the Fourth Quarter and Year Ended December 31, 2014; Provides Revenue Guidance for the Full Year of 2015

CareDx Inc. announced financial results for the fourth quarter and year ended December 31, 2014. Revenue for the three months ended December 31, 2014 increased 36% to $8.0 million, from $5.9 million in the same period in 2013. Of the $8.0 million in revenue, $1.1 million was associated with the payments from LabCorp. For the fourth quarter of 2014, net loss was $5,000 and basic and diluted net income per share was $0.00, compared to $562,000 or $0.56 per diluted share a year ago. Income from operations was $429,000 compared to $509,000 a year ago. Loss before income taxes was $5,000 compared to $562,000 a year ago. For the full year 2014, revenues were $27.3 million versus $22.1 million in 2013, an increase of 24%. Net income for fiscal year 2014 was $781,000 compared to a net loss of $3.5 million for fiscal year 2013. Basic and diluted income per share were $0.13 and $0.10 for fiscal year 2014 compared to a $3.50 loss for both basic and diluted earnings per share for fiscal year 2013. Income from operations was $1,250,000 compared to loss of $857,000 a year ago. Loss before income taxes was $719,000 compared to $3,542,000 a year ago. The company is providing revenue guidance for the full year of 2015. Revenue is expected to be in the range of $28 million to $30 million.

CareDx, Inc to Report Q4, 2014 Results on Mar 17, 2015

CareDx, Inc announced that they will report Q4, 2014 results at 5:00 PM, Eastern Standard Time on Mar 17, 2015


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CDNA:US $5.02 USD -0.35

CDNA Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for CDNA.
View Industry Companies

Industry Analysis


Industry Average

Valuation CDNA Industry Range
Price/Earnings 59.7x
Price/Sales 2.2x
Price/Book 1.4x
Price/Cash Flow 75.9x
TEV/Sales 0.4x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CAREDX INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at